Green Tea Epigallocatechin 3-Gallate Reduced Platelet Aggregation and Improved Anticoagulant Proteins in Patients with Transfusion-Dependent β-Thalassemia: A Randomized Placebo-Controlled Clinical Trial

Overview

Journal Foods

Specialty Biotechnology

Date 2024 Dec 17

PMID 39682935

Authors

Touchwin Petiwathayakorn

Sasinee Hantrakool

Kornvipa Settakorn

Nuntouchaporn Hutachok

Adisak Tantiworawit

Nopphadol Chalortham

Pimpisid Koonyosying

Somdet Srichairatanakool

Affiliations

Soon will be listed here.

Abstract

Patients with transfusion-dependent β-thalassemia (TDT) with iron overload have been linked to hypercoagulability and increased platelet (PLT) activation that causes thrombosis. Green tea extract (GTE) rich in epigallocatechin-3-gallate (EGCG) exerts iron-chelating and antithrombotic properties. The study aimed to assess the effects of GTE treatment on plasma coagulation state and PLT function in vitro and in patients with TDT. The subjects consumed a placebo or GTE tablets (50 mg and 2 × 50 mg EGCG equivalent) every day for two months. Blood was then collected from the treated patients for analyses of PLT numbers, agonist-induced PLT aggregation, and anti-coagulation proteins. In our findings indicate that the in vitro treatment of GTE (at least 1 mg EGCG equivalent) inhibited PLT aggregation in patients who were healthy and with thalassemia platelet-rich plasma (PRP), which was significant in the healthy PRP. Consistently, GTE treatment inhibited the PLT aggregation that had been ex vivo generated by collagen or ADP. In addition, consumption of GTE tablets greatly inhibited PLT aggregation and increased the plasma levels of proteins C and S, as well as the free protein S concentrations depending upon the time course, but not the GTE dosage. Moreover, plasma ferritin levels decreased in both green tea tablet groups in a time-dependent manner ( < 0.05 in the second month). In conclusion, EGCG-rich GTE diminished PLT aggregation in patients who were healthy and patients with thalassemia plasma. It also improved PLT aggregation and hypercoagulability in patients with TDT by increasing the antithrombotic activity of protein C and protein S. This would suggest an adjuvant of GTE could reduce the risk of thrombosis associated with iron overload.

References

Atichartakarn V, Angchaisuksiri P, Aryurachai K, Onpun S, Chuncharunee S, Thakkinstian A . Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients. Br J Haematol. 2002; 118(3):893-8. DOI: 10.1046/j.1365-2141.2002.03711.x. View

Erb L, Weisman G . Coupling of P2Y receptors to G proteins and other signaling pathways. Wiley Interdiscip Rev Membr Transp Signal. 2015; 1(6):789-803. PMC: 4358762. DOI: 10.1002/wmts.62. View

Dissayabutra T, Tosukhowong P, Seksan P . The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress. J Med Assoc Thai. 2006; 88 Suppl 4:S317-21. View

Klaihmon P, Lertthammakiat S, Anurathapan U, Pakakasama S, Sirachainan N, Hongeng S . Activated platelets and leukocyte activations in young patients with β-thalassemia/HbE following bone marrow transplantation. Thromb Res. 2018; 169:8-14. DOI: 10.1016/j.thromres.2018.07.007. View

Akrawinthawong K, Park J, Piknova B, Sibmooh N, Fucharoen S, Schechter A . A flow cytometric analysis of the inhibition of platelet reactivity due to nitrite reduction by deoxygenated erythrocytes. PLoS One. 2014; 9(3):e92435. PMC: 3958531. DOI: 10.1371/journal.pone.0092435. View

Atichartakarn V, Chuncharunee S, Chandanamattha P, Likittanasombat K, Aryurachai K . Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient. Blood. 2003; 103(7):2844-6. DOI: 10.1182/blood-2003-09-3094. View

Perret-Guillaume C, Wahl D . Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose--a meta-analysis. Thromb Haemost. 2004; 91(2):394-402. DOI: 10.1160/TH03-08-0541. View

Panfili G, Fratianni A, Irano M . Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals. J Agric Food Chem. 2003; 51(14):3940-4. DOI: 10.1021/jf030009v. View

Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332. PMC: 2844940. DOI: 10.1136/bmj.c332. View

10.

Audomkasok S, Singpha W, Chachiyo S, Somsak V . Antihemolytic Activities of Green Tea, Safflower, and Mulberry Extracts during Plasmodium berghei Infection in Mice. J Pathog. 2014; 2014:203154. PMC: 4251073. DOI: 10.1155/2014/203154. View

11.

Polette A, Blache D . Effect of vitamin E on acute iron load-potentiated aggregation, secretion, calcium uptake and thromboxane biosynthesis in rat platelets. Atherosclerosis. 1992; 96(2-3):171-9. DOI: 10.1016/0021-9150(92)90063-m. View

12.

Sang S, Lambert J, Ho C, Yang C . The chemistry and biotransformation of tea constituents. Pharmacol Res. 2011; 64(2):87-99. DOI: 10.1016/j.phrs.2011.02.007. View

13.

Ghosal T, Dolai T, Mandal P, Karthik S, Bandyopadhyay A . Platelet Aggregation Study in Patients With Hemoglobin Eβ Thalassemia in India. Clin Appl Thromb Hemost. 2015; 22(6):575-80. DOI: 10.1177/1076029615573302. View

14.

Day S, Duquaine D, Mundada L, Menon R, Khan B, Rajagopalan S . Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation. 2003; 107(20):2601-6. DOI: 10.1161/01.CIR.0000066910.02844.D0. View

15.

Saewong T, Ounjaijean S, Mundee Y, Pattanapanyasat K, Fucharoen S, Porter J . Effects of green tea on iron accumulation and oxidative stress in livers of iron-challenged thalassemic mice. Med Chem. 2010; 6(2):57-64. DOI: 10.2174/157340610791321479. View

16.

Tomaiuolo M, Brass L, Stalker T . Regulation of Platelet Activation and Coagulation and Its Role in Vascular Injury and Arterial Thrombosis. Interv Cardiol Clin. 2016; 6(1):1-12. PMC: 5154246. DOI: 10.1016/j.iccl.2016.08.001. View

17.

Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K . Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health. 1992; 23 Suppl 2:65-73. View

18.

Uckoo R, K Jayaprakasha G, Nelson S, Patil B . Rapid simultaneous determination of amines and organic acids in citrus using high-performance liquid chromatography. Talanta. 2010; 83(3):948-54. DOI: 10.1016/j.talanta.2010.10.063. View

19.

Kang W, Lim I, Yuk D, Chung K, Park J, Yoo H . Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res. 1999; 96(3):229-37. DOI: 10.1016/s0049-3848(99)00104-8. View

20.

Cabrera C, Artacho R, Gimenez R . Beneficial effects of green tea--a review. J Am Coll Nutr. 2006; 25(2):79-99. DOI: 10.1080/07315724.2006.10719518. View